These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 8658015)

  • 1. Genetic clinical markers of human neuroblastoma with special reference to N-myc oncogene: amplified or not amplified?--An overview.
    Tsuchida Y; Hemmi H; Inoue A; Obana K; Yang HW; Hayashi Y; Kanda N; Shimatake H
    Tumour Biol; 1996; 17(2):65-74. PubMed ID: 8658015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neuroblastoma cell lines that express N-myc without gene amplification.
    Wada RK; Seeger RC; Brodeur GM; Einhorn PA; Rayner SA; Tomayko MM; Reynolds CP
    Cancer; 1993 Dec; 72(11):3346-54. PubMed ID: 8242562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
    Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
    Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
    Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.
    Caron H; Peter M; van Sluis P; Speleman F; de Kraker J; Laureys G; Michon J; Brugières L; Voûte PA; Westerveld A
    Hum Mol Genet; 1995 Apr; 4(4):535-9. PubMed ID: 7633401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where pathology meets molecular biology: N-myc amplification in human neuroblastoma as a paradigm for the clinical use of an oncogene alteration.
    Schwab M
    Verh Dtsch Ges Pathol; 1994; 78():26-33. PubMed ID: 7533996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
    Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications.
    Brodeur GM; Seeger RC
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):101-11. PubMed ID: 3940169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
    Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
    Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
    Schwab M
    Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
    Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
    Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
    Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas.
    Schwab M
    Brain Pathol; 1990 Sep; 1(1):41-6. PubMed ID: 1669692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.